Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity

Abstract

A decrease in serum estrogen levels in menopause is closely associated with the development of visceral obesity and the onset of type 2 diabetes in women. In the present study, we demonstrated the therapeutic effects of the novel DPP4 inhibitor, teneligliptin, on the features of postmenopausal obesity in mice. In the control group, female C57BL/6 mice were sham-operated and maintained on a standard diet. In the postmenopausal obese group, ovariectomized (OVX) mice were maintained on a high-fat diet, and were referred to as OVX-HF. In the treated group, teneligliptin at 60 mg/kg per day was administrated to OVX-HF, and were referred to as Tene. After a 12-week food challenge, the metabolic phenotypes of these mice were analyzed. Body weight, fat accumulation, and glucose intolerance were greater in OVX-HF than in control, while these abnormalities were markedly improved without alterations in calorie intake in Tene. Teneligliptin effectively ameliorated the characteristics of metabolic abnormalities associated with postmenopausal obesity. Regarding chronic inflammation in visceral adipose tissue, the numbers of F4/80K M1-macrophages in flow cytometry, crown-like structure formation in immunohistochemistry, and proinflammatory cytokine expression were significantly attenuated in Tene. Hepatic steatosis was also markedly improved. Furthermore, decreased energy consumption in the dark and light phases, reduced locomotor activity in the dark phase, and lowered core body temperature in OVX-HF were ameliorated in Tene. Since obesity and reduced energy metabolism are a common physiology of menopause, teneligliptin appears to be beneficial as a treatment for type 2 diabetes in postmenopausal obesity. Key Words" dpp4 inhibitor " adipose tissue macrophage " energy expenditure " insulin resistance

Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance

“…Serum levels of insulin were measured using an ELISA kit (Morinaga, Kanagawa, Japan). Serum levels of cholesterol and triglycerides were determined with a colorimetric kit (Wako Pure Chemical, Osaka, Japan) (Wada et al 2013, Sameshima et al 2015. Hepatic triglyceride content was determined using a triglyceride colorimetric kit (Wako Pure Chemical) after extraction of the lipid fraction from frozen liver specimens by the method of Bligh and Dyer with minor modifications (Wada et al 2013).…”

“…The inter-assay coefficients of variation were less than 10% in each analysis. Glucose tolerance test (GTT) and insulin tolerance test (ITT) were conducted as described previously (Sameshima et al 2015, Onogi et al 2017.…”

Estrogen regulates sex-specific localization of regulatory T cells in adipose tissue of obese female mice

“…For the GTT, mice fasted for 6 h were injected intraperitoneally with glucose (2g/kg body weight). For the ITT, mice fasted for 2 h were injected intraperitoneally with insulin (0.75 U/kg body weight) [17,18].…”

Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes

“…In conclusion, these studies consistently demonstrate that DPP4 inhibition provides endothelial protection through suppression of inflammation. Thus, aside from improving metabolic control [78], DPP4 inhibitors can suppress autoimmune processes leading to diabetic vasculopathy.…”